# Topical Application of Imiquimod Gel at Different Concentrations in Actinic Cheilitis

> **NCT04219358** · PHASE1 · TERMINATED · sponsor: **Hospital de Clinicas de Porto Alegre** · enrollment: 49 (actual)

## Conditions studied

- Actinic Cheilitis

## Interventions

- **DRUG:** Vehicle Gel Base
- **DRUG:** Imiquimod 5% gel
- **DRUG:** Imiquimod 0,05% gel
- **DRUG:** Imiquimod nanoencapsulated 0,05% gel
- **DRUG:** Lip sunscreen 30 Sun Protector Factor (SPF)
- **DRUG:** Dexpanthenol

## Key facts

- **NCT ID:** NCT04219358
- **Lead sponsor:** Hospital de Clinicas de Porto Alegre
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-23
- **Primary completion:** 2020-06-24
- **Final completion:** 2021-08-24
- **Target enrollment:** 49 (ACTUAL)
- **Why stopped:** Study terminated because of COVID19 pandemics.
- **Last updated:** 2022-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04219358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04219358, "Topical Application of Imiquimod Gel at Different Concentrations in Actinic Cheilitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04219358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*